| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Courses and Workshops |
|
|
| |
| |
| |
March 14, 2011 |
|
|
| |
|
|
| |
|
|
|
Hyatt Regency Boston, Boston, MA USA
Aug 17 2011 8:30AM - Aug 18 2011 2:30PM
Learn Regulatory Requirements for Biologics
Discuss proven strategies to achieve regulatory compliance for the development of biologics. What you will learn
• Difference between traditional biologics and biotechnology products
• Regulatory needs and requirements for biologics
• Unique aspects in the development of specific biologics such as vaccines and gene therapy
• Differences in how CBER views product development compared to CDER Event Code:
11431
|
|
|
|
|
|
|
|
Organized by:
|
|
DIA |
|
|
Invited Speakers:
|
|
Call contact
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
Call contact
|
|
|
|
|
|
|
|
Registration:
|
|
Contact Information:
For detailed program information including faculty and topics, please contact:
Susan Mazak
Tel. +1-215-442-6183
|
|
|
E-mail:
|
|
susan.mazak@diahome.org
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|